MedPath

Weight Regain After Consumption of Food Supplement and Interventional Diet Program

Phase 3
Completed
Conditions
Weight Loss
Weight Change, Body
Obesity
Body Weight Changes
Overweight
Interventions
Dietary Supplement: Fat-binder damm
Dietary Supplement: Placebo
Registration Number
NCT03554525
Lead Sponsor
Instituto de Investigación Hospital Universitario La Paz
Brief Summary

Effect of the dietary supplement (FAT-BINDER DAMM) on weight regain after 9 months of control weight program

Detailed Description

* 60 participants will consume experimental product every day 3 sticks of the dietary supplement (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the 12 first weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period). When PPP period is over, volunteers will continue consuming the product for 9 months more (Post-PPP period).

* 60 participants will consume everyday 3 placebo sticks (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the first 12 weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period ). When PPP period is over, volunteers will continue consuming the product for 9 months more.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Men and women ranging from 18 to 65 years old.
  • BMI ≥27 and <40 kg/m2. Overweight type II, obesity type I and II
  • Social or familiar environment that prevents from accomplishing the dietary treatment.
  • Willingness to follow a balanced hypocaloric diet in order to lose weight and perform regular physical adapted activity.
  • Adequate cultural level and understanding of the clinical trial.
  • Signed informed consent.
Exclusion Criteria
  • Individuals diagnosed with Diabetes Mellitus type I.
  • Individuals diagnosed with Diabetes Mellitus type II on pharmacological treatment.
  • Individuals with dyslipidemia on pharmacological treatment.
  • Individuals with hypertension on pharmacological treatment uncontrolled.
  • Individuals allergic to yeast.
  • Individuals with chronic diseases (hepatic, kidney...).
  • Individuals who have participated in the last 6 months in a program or clinical trial to lose weight.
  • Individuals receiving at least the preceding 2 months a pharmacological treatment that modifies the lipid profile (for example, statins, fibrates, diuretics, corticosteroids, ADOs).
  • Pregnant or breastfeeding women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental product : FAT-BINDER DAMMFat-binder damm3 sticks of the dietary supplement (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner.
Control product : PLACEBOPlacebo3 sticks of the dietary supplement (1.4grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner.
Primary Outcome Measures
NameTimeMethod
Weight Regain12 months

Change from baseline in kilograms

Secondary Outcome Measures
NameTimeMethod
24 hours Dietary Recall12 months

24 hours Food habits of overweight and obesity people

Fiber12 months

Change from baseline

International Physical Activity Questionnaire12 months

People physical activity habits

High density lipoprotein cholesterol12 months

Change from baseline

Low density lipoprotein cholesterol12 months

Change from baseline

Lean mass percentage12 months

Change from baseline in percentage

Fat mass percentage12 months

Change from baseline in percentage

Satiety evaluation[Just before eating the product; Just after eating; After 60 minutes; After 90 minutes] Fasting for at least 4 hours. Must do it with a snack accompanied and 500 ml water.

Visual Analog Scale to evaluate motivation-satiety when eating

Sensory perceptionMonths 6, 7, 8 y 9. Gustatory and olfactory sensory perception of the subjects for the study products.

Questionnaire of analysis of sensory perception of the food study product. Five questions that are valued on a scale of 0% to 100% asking about the taste and smell of the study product: desire with which the product is taken, taste, smell, consistency and what wait for effectiveness.

Body Mass Index (weight/height^2)12 months

Change from baseline in kg/m\^2

Body water percentage12 months

Change from baseline in percentage

Triglycerides12 months

Change from baseline

Trial Locations

Locations (1)

Institute for Health Research IdiPAZ

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath